Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Human Health Holdings stock price, quote, forecast and news

1419.HK
KYG4644Q1091

Price

1.00 HKD
Today +/-
+0 HKD
Today %
+0 %
P

Human Health Holdings stock price

HKD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Human Health Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Human Health Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Human Health Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Human Health Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Human Health Holdings Stock Price History

DateHuman Health Holdings Price
9/5/20241.00 HKD
9/4/20241.00 HKD
9/3/20241.01 HKD
9/2/20241.01 HKD
8/30/20241.00 HKD
8/29/20241.00 HKD
8/28/20241.03 HKD
8/27/20241.03 HKD
8/26/20241.04 HKD
8/23/20241.04 HKD
8/22/20241.04 HKD
8/21/20241.05 HKD
8/20/20241.05 HKD
8/19/20241.03 HKD
8/16/20241.03 HKD
8/15/20241.03 HKD
8/14/20241.05 HKD
8/13/20241.05 HKD
8/12/20241.05 HKD

Human Health Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Human Health Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Human Health Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Human Health Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Human Health Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Human Health Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Human Health Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Human Health Holdings’s growth potential.

Human Health Holdings Revenue, EBIT and net profit per share

DateHuman Health Holdings RevenueHuman Health Holdings EBITHuman Health Holdings Net Income
20231 B HKD308.51 M HKD180.84 M HKD
20221.12 B HKD429.63 M HKD375.31 M HKD
2021654.71 M HKD146.2 M HKD144.45 M HKD
2020453.74 M HKD-12.4 M HKD-40.37 M HKD
2019528.59 M HKD35.97 M HKD26.62 M HKD
2018518.02 M HKD38.66 M HKD24.11 M HKD
2017481.15 M HKD24.55 M HKD13.47 M HKD
2016498.58 M HKD52.47 M HKD23.43 M HKD
2015429.54 M HKD45.1 M HKD33.73 M HKD
2014365.2 M HKD49.3 M HKD38.7 M HKD
2013333.9 M HKD43.5 M HKD34.1 M HKD

Human Health Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B HKD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M HKD)EBIT (M HKD)EBIT MARGIN (%)NET INCOME (M HKD)NET INCOME GROWTH (%)DIV. (HKD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
20132014201520162017201820192020202120222023
0.330.370.430.50.480.520.530.450.651.121
-9.6117.5316.08-3.417.691.93-14.2044.3771.41-10.70
45.6547.4046.3947.3946.9946.9146.9741.7257.4958.7959.24
152173199236226243248189376659593
43494552243835-12146429308
12.9113.4210.4910.444.997.346.63-2.6522.3238.2730.77
34383323132426-40144375180
-11.76-13.16-30.30-43.4884.628.33-253.85-460.00160.42-52.00
-----------
-----------
273.3273.3273.32294.62361.5361.5371.54379.55379.55379.55379.55
-----------
Details

Keystats

ⓘ

Revenue and Growth

The Human Health Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Human Health Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M HKD)RECEIVABLES (M HKD)OTHER REC. (M HKD)INVENTORIES (M HKD)OTHER CURRENT LIAB. (M HKD)CURRENT ASSETS (M HKD)TANGIBLE ASSETS (M HKD)LONG-T. INVEST. (M HKD)LONG-T. REC. (M HKD)INTANGIBLE ASSETS (M HKD)GOODWILL (M HKD)OTHER NON-CURRENT ASSETS (M HKD)NON-CURRENT ASSETS (M HKD)TOTAL ASSETS (B HKD)LIABILITIESCOMMON STOCK (M HKD)ADDITIONAL PAID-IN CAPITAL (M HKD)RETAINED EARNINGS (M HKD)OTHER EQUITY (M HKD)UNREAL. GAINS/LOSSES (M HKD)EQUITY (M HKD)LIABILITIES (M HKD)PROVISIONS (M HKD)OTHER SHORT-TERM LIAB. (M HKD)SHORT-TERM DEBTS (M HKD)LONG-TERM DEBT PORTION (M HKD)SHORT-TERM REC. (M HKD)LONG-T. LIAB. (M HKD)DEFERRED TAXES (M HKD)OTHER LIAB. (M HKD)LONG-T. LIABILITIES (M HKD)DEBT (M HKD)TOTAL CAPITAL (B HKD)
20132014201520162017201820192020202120222023
                     
88.391.4109.2170.23170.81187.75158.62122.62145.27270.33641.26
21.424.831.933.0131.4531.9433.1236.02233.49422.34101.63
3.55.22.74.83.981.341.769.385.191.32.11
3.74.87.36.997.67.4913.0712.113.9618.3328.33
4.35.713.29.5713.8513.8410.8511.9317.9719.6323.67
121.2131.9164.3224.6227.69242.36217.42192.05415.87731.93796.99
9.510.512.19.9915.8417.6417.27103.4565.34224.38221.86
2.83.1018.8913.6710.75101.1470.7569.84122.89132.55
00000010.800011.34
0016.715.0513.4411.8210.218.66.995.383.77
003231.9631.9631.9631.9631.9631.9631.9631.96
8.88.66.918.6317.5828.8819.8721.1822.3842.0865.01
21.122.267.794.5192.49101.05191.26235.95196.52426.68466.49
0.140.150.230.320.320.340.410.430.611.161.26
                     
0061.23.623.623.623.83.83.83.83.8
000164.95164.95164.95190.22190.22190.22190.22190.22
85.688.353.846.987.57105.05120.5766.29216.51548.57616.17
000-0.76-1.21-0.04-0.99-1.25-0.4-0.64-1.97
00000000000
85.688.3115214.7254.93273.58313.6259.05410.13741.95808.22
1719.128.427.2123.6625.4431.1119.1234.1940.3857.36
00000010.583.6732.2239.9138.04
31.436.985.832.5434.9637.2137.9838.9365.49139.35169.14
00038.37009.4915.5511.6642.2236.51
000000052.4541.7639.2548.13
48.456114.298.1258.6362.6589.16129.72185.32301.09349.18
000000034.1713.66107.0197.85
0.10.12.82.692.562.151.871.61.340.890.62
0003.592.454.384.053.461.947.687.62
0.10.12.86.295.016.525.9239.2316.94115.57106.09
48.556.1117104.4163.6469.1795.08168.95202.26416.67455.27
0.130.140.230.320.320.340.410.430.611.161.26
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Human Health Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Human Health Holdings's financial health and stability.

Assets

Human Health Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Human Health Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Human Health Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Human Health Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M HKD)DEPRECIATION (M HKD)DEFERRED TAXES (M HKD)CHANGES IN WORKING CAPITAL (M HKD)NON-CASH ITEM (M HKD)PAID INTEREST (M HKD)PAID TAXES (M HKD)NET CASH FLOW FROM OPERATING ACTIVITIES (M HKD)CAPITAL EXPENDITURES (M HKD)CASH FLOW FROM INVESTING ACTIVITIES (M HKD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M HKD)INTEREST INCOME AND EXPENSES (M HKD)NET DEBT CHANGE (M HKD)NET CHANGE IN EQUITY (M HKD)CASH FLOW FROM FINANCING ACTIVITIES (M HKD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M HKD)TOTAL DIVIDENDS PAID (M HKD)NET CHANGE IN CASH FLOW (M HKD)FREE CASH FLOW (M HKD)SHARE-BASED COMPENSATION (M HKD)
20132014201520162017201820192020202120222023
43494535203134-39168445238
65689101275676374
00000000000
-10-133-24-11-22-23-158-199279
0001471247-1371
00000004227
810810147424455
384155212247503785295664
-5-7-5-3-12-8-8-11-14-76-84
-5-6-31-5611-43-69-18-4-203-335
01-26-5223-34-60-79-126-251
00000000000
0004209-49-55-19-56
0001210000000
-18-31-564-6-7-1-64-59-67-178
-18-31-5-11200-4-2-2-7
000-49-10-7-10-100-45-113
143172926-2-20-462224149
33.133.3649.5517.659.638.6742.126.0371.44219.3580.24
00000000000

Human Health Holdings stock margins

The Human Health Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Human Health Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Human Health Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Human Health Holdings's sales revenue. A higher gross margin percentage indicates that the Human Health Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Human Health Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Human Health Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Human Health Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Human Health Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Human Health Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Human Health Holdings Margin History

Human Health Holdings Gross marginHuman Health Holdings Profit marginHuman Health Holdings EBIT marginHuman Health Holdings Profit margin
202359.22 %30.8 %18.05 %
202258.81 %38.3 %33.46 %
202157.54 %22.33 %22.06 %
202041.84 %-2.73 %-8.9 %
201946.96 %6.81 %5.04 %
201847.02 %7.46 %4.65 %
201747 %5.1 %2.8 %
201647.45 %10.52 %4.7 %
201546.39 %10.5 %7.85 %
201447.56 %13.5 %10.6 %
201345.58 %13.03 %10.21 %

Human Health Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Human Health Holdings earnings per share therefore indicates how much revenue Human Health Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Human Health Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Human Health Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Human Health Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Human Health Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Human Health Holdings Revenue, EBIT and net profit per share

DateHuman Health Holdings Sales per ShareHuman Health Holdings EBIT per shareHuman Health Holdings Earnings per Share
20232.64 HKD0.81 HKD0.48 HKD
20222.96 HKD1.13 HKD0.99 HKD
20211.72 HKD0.39 HKD0.38 HKD
20201.2 HKD-0.03 HKD-0.11 HKD
20191.42 HKD0.1 HKD0.07 HKD
20181.43 HKD0.11 HKD0.07 HKD
20171.33 HKD0.07 HKD0.04 HKD
20161.69 HKD0.18 HKD0.08 HKD
20151.57 HKD0.17 HKD0.12 HKD
20141.34 HKD0.18 HKD0.14 HKD
20131.22 HKD0.16 HKD0.12 HKD

Human Health Holdings business model

Human Health Holdings is one of the most popular companies on Eulerpool.com.

Human Health Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Human Health Holdings historical P/E ratio, EBIT, and P/S ratio.

Human Health Holdings shares outstanding

The number of shares was Human Health Holdings in 2023 — This indicates how many shares 379.552 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Human Health Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Human Health Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Human Health Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Human Health Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Human Health Holdings dividend history and estimates

In 2023, Human Health Holdings paid a dividend amounting to 0.16 HKD. Dividend means that Human Health Holdings distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Human Health Holdings provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Human Health Holdings’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Human Health Holdings's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Human Health Holdings Dividend History

DateHuman Health Holdings Dividend
20230.16 HKD
20220.3 HKD
20210.12 HKD
20190.03 HKD
20180.03 HKD
20170.02 HKD
20160.03 HKD

Human Health Holdings dividend payout ratio

In 2023, Human Health Holdings had a payout ratio of 32.15%. The payout ratio indicates the percentage of the company's profits that Human Health Holdings distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Human Health Holdings represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Human Health Holdings could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Human Health Holdings's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Human Health Holdings Payout Ratio History

DateHuman Health Holdings Payout ratio
202332.15 %
202230.34 %
202131.53 %
202034.58 %
201941.86 %
201844.98 %
201753.68 %
201637.72 %
201534.58 %
201434.58 %
201334.58 %
Unfortunately, there are currently no price targets and forecasts available for Human Health Holdings.

Human Health Holdings list of shareholders

%
Name
Stocks
Change
Date
66.48530 % Treasure Group Global Ltd.252,346,28606/30/2023
1.80476 % Chan (Kin Ping)6,850,00006/30/2023
0.12805 % Poon (Chun Pong)486,00006/30/2023
1

Human Health Holdings Executives and Management Board

Dr. Chui Wan Sat54
Human Health Holdings Chief Financial Officer, Executive Director (since 2013)
Compensation 3.38 M HKD
Mr. Chun Pong Poon43
Human Health Holdings Chief Operating Officer, Executive Director (since 2013)
Compensation 3.12 M HKD
Mr. Kin Ping Chan58
Human Health Holdings Executive Chairman of the Board, Chief Executive Officer
Compensation 3.01 M HKD
Mr. Lai Sheung Pang55
Human Health Holdings Chief Medical Officer, Executive Director
Compensation 3.01 M HKD
Mr. Yue Kwong Chan69
Human Health Holdings Non-Executive Independent Director
Compensation 180,000 HKD
1
2
3

Most common questions regarding Human Health Holdings

What is the P/E ratio of Human Health Holdings 2024?

The P/E ratio cannot be calculated for Human Health Holdings at the moment.

What is the P/S ratio of Human Health Holdings 2024?

The P/S cannot be calculated for Human Health Holdings currently.

What is the AlleAktien quality score of Human Health Holdings?

The AlleAktien quality score for Human Health Holdings is 7/10.

What is the revenue of Human Health Holdings 2024?

The revenue cannot currently be calculated for Human Health Holdings.

How high is the profit of Human Health Holdings 2024?

The profit cannot currently be calculated for Human Health Holdings.

What is the business model of Human Health Holdings

No history available for Human Health Holdings.

What is the Human Health Holdings dividend?

Human Health Holdings pays a dividend of 0.3 HKD distributed over payouts per year.

How often does Human Health Holdings pay dividends?

The dividend cannot currently be calculated for Human Health Holdings or the company does not pay out a dividend.

What is the Human Health Holdings ISIN?

The ISIN of Human Health Holdings is KYG4644Q1091.

What is the Human Health Holdings ticker?

The ticker of Human Health Holdings is 1419.HK.

How much dividend does Human Health Holdings pay?

Over the past 12 months, Human Health Holdings paid a dividend of 0.16 HKD . This corresponds to a dividend yield of about 16 %. For the coming 12 months, Human Health Holdings is expected to pay a dividend of 0.16 HKD.

What is the dividend yield of Human Health Holdings?

The current dividend yield of Human Health Holdings is 16 %.

When does Human Health Holdings pay dividends?

Human Health Holdings pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Human Health Holdings?

Human Health Holdings paid dividends every year for the past 3 years.

What is the dividend of Human Health Holdings?

For the upcoming 12 months, dividends amounting to 0.16 HKD are expected. This corresponds to a dividend yield of 16 %.

In which sector is Human Health Holdings located?

Human Health Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Human Health Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Human Health Holdings from 12/29/2023 amounting to 0.16 HKD, you needed to have the stock in your portfolio before the ex-date on 12/11/2023.

When did Human Health Holdings pay the last dividend?

The last dividend was paid out on 12/29/2023.

What was the dividend of Human Health Holdings in the year 2023?

In the year 2023, Human Health Holdings distributed 0.3 HKD as dividends.

In which currency does Human Health Holdings pay out the dividend?

The dividends of Human Health Holdings are distributed in HKD.

All fundamentals about Human Health Holdings

Our stock analysis for Human Health Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Human Health Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.